Accurately Assessing the Expected Impact of Universal First Respiratory Syncytial Virus (RSV) Season Immunization With Nirsevimab Against RSV-Related Outcomes and Costs Among All US Infants
J Infect Dis. 2023 May 29;227(11):1333-1334.
doi: 10.1093/infdis/jiac488.